Prevalence of Obesity-Related Glomerulopathy in Morbidly Obese Patients at Cairo University Tertiary Hospital

Amir K. Abosayed; Hesham Ahmed Abou Aisha; Ehab Fathy; Ahmed Mohammed Salah Eldeen Othman ElAnsary; Ahmad Abd Al Aziz

doi:10.3889/oamjms.2022.9121

Authors

Amir K. Abosayed Department of General Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
Hesham Ahmed Abou Aisha Department of General Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
Ehab Fathy Department of General Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
Ahmed Mohammed Salah Eldeen Othman ElAnsary Department of General Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
Ahmad Abd Al Aziz Department of General Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt

DOI:

https://doi.org/10.3889/oamjms.2022.9121

Keywords:

Obesity, ORG, Albuminuria, CKD

Abstract

BACKGROUND: Obesity has been reported to be a risk factor for chronic kidney disease and albuminuria. Obesity-related glomerulopathy (ORG) usually has a gradual onset, with microalbuminuria or clinically dominant proteinuria as the primary manifestation, with or without impaired renal function, and a small number of patients manifesting with microscopic hematuria or nephrotic syndrome.

AIM: The present study aimed to evaluate the prevalence of ORG in morbidly obese patients and its impact on renal function.

PATIENTS AND METHODS: This is a descriptive cross-sectional study that included patients with morbid obesity who visited the bariatric clinic in our institution during the period from October 2019 to February 2021. Patients who had no history of diabetes mellitus (DM) or hypertension underwent blood pressure measurement, assessment for 24-h urinary albumin to detect patients with laboratory-based ORG, kidney function tests, urine analysis and HbA1c, and examination by abdominal sonogram focused on both kidneys. Patients with asymptomatic micro or macroalbuminuria were recruited to the study.

RESULTS: The total number of patients screened during the study period was 1,045, out of whom 100 patients were eligible for the study according to the inclusion and exclusion criteria, denoting an albuminuria prevalence of 9.5% and there is no statistically significant relationship between this albuminuria and age, gender, and BMI.

CONCLUSION: ORG is a rising problem in the field of morbid obesity management, the current study shows that the prevalence of ORG is 9.5% in our screened cohort.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13-27. https://doi.org/10.1056/NEJMoa1614362 PMid:28604169 DOI: https://doi.org/10.1056/NEJMoa1614362

Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterol Clin North Am. 2016;45(4):571-9. https://doi.org/10.1016/j.gtc.2016.07.012 PMid:27837773 DOI: https://doi.org/10.1016/j.gtc.2016.07.012

Abarca-Gómez L, Abdeen ZA, Hamid ZA. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-42. https://doi.org/10.1016/S0140-6736(17)32129-3 PMid:29029897 DOI: https://doi.org/10.1016/S0140-6736(17)32129-3

Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering C. Obesity and kidney disease: Hidden consequences of the epidemic. Can J Kidney Health Dis. 2017;4:1-10. DOI: https://doi.org/10.1111/jorc.12194

Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles GM, Flax C, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440-50. https://doi.org/10.1056/NEJMsa1909301 PMid:31851800 DOI: https://doi.org/10.1056/NEJMsa1909301

Jimenez-Mora MA, Nieves-Barreto LD, Montano-Rodriguez A, Betancourt-Villamizar EC, Mendivil CO. Association of overweight, obesity and abdominal obesity with socioeconomic status and educational level in Colombia. Diabetes Metab Syndr Obes. 2020;13:1887-98. https://doi.org/10.2147/DMSO.S244761 PMid:32581563 DOI: https://doi.org/10.2147/DMSO.S244761

Gregg EW, Shaw JE. Global health effects of overweight and obesity. N Engl J Med. 2017;377(1):80-1. https://doi.org/10.1056/NEJMe1706095 PMid:28604226 DOI: https://doi.org/10.1056/NEJMe1706095

De Vries AP, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, et al. Fatty kidney: Emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2(5):417-26. https://doi.org/10.1016/S2213-8587(14)70065-8 PMid:24795255 DOI: https://doi.org/10.1016/S2213-8587(14)70065-8

Hall JE, Mouton AJ, Da Silva AA, Omoto AC, Wang Z, Li X, et al. Obesity, kidney dysfunction, and inflammation: Interactions in hypertension. Cardiovasc Res. 2021;117(8):1859-76. https://doi.org/10.1093/cvr/cvaa336 PMid:33258945 DOI: https://doi.org/10.1093/cvr/cvaa336

Tsuboi N, Koike K, Hirano K, Utsunomiya Y, Kawamura T, Hosoya T. Clinical features and long-term renal outcomes of Japanese patients with obesity-related glomerulopathy. Clin Exp Nephrol. 2013;17(3):379-85. https://doi.org/10.1007/s10157-012-0719-y PMid:23135866 DOI: https://doi.org/10.1007/s10157-012-0719-y

Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: Anemerging epidemic. Kidney Int. 2001;59(4):1498-509. https://doi.org/10.1046/j.1523-1755.2001.0590041498.x PMid:11260414 DOI: https://doi.org/10.1046/j.1523-1755.2001.0590041498.x

Praga M, Hernández E, Morales E, Campos AP, Valero MA, Martínez MA, et al. Clinical features and long-term outcome of obesity‐associated focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2001;16:1790-8. https://doi.org/10.1093/ndt/16.9.1790 PMid:11522860 DOI: https://doi.org/10.1093/ndt/16.9.1790

Chen HM, Liu ZH, Zeng CH, Li SJ, Wang QW, Li LS. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis. 2006;48(5):772-9. https://doi.org/10.1053/j.ajkd.2006.07.025 PMid:17059996 DOI: https://doi.org/10.1053/j.ajkd.2006.07.025

Cho H, Kim JH. Prevalence of microalbuminuria and its associated cardiometabolic risk factors in Korean youth: Data from the Korea national health and nutrition examination survey. PLoS One. Public Lib Sci. 2017;12(6):01787. https://doi.org/10.1371/journal.pone.0178716 PMid:28575100 DOI: https://doi.org/10.1371/journal.pone.0178716

Rosenstock JL, Pommier M, Stoffels G, Patel S, Michelis MF. Prevalence of proteinuria and albuminuria in an obese population and associated risk factors. Front Med (Lausanne). 2018;5:122. https://doi.org/10.3389/fmed.2018.00122 PMid:29761105 DOI: https://doi.org/10.3389/fmed.2018.00122

Pinto-Sietsma SJ, Navis G, Janssen WM, De Zeeuw D, Gans RO, De Jong PE, et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis. 2003;41:733-41. https://doi.org/10.1016/s0272-6386(03)00020-9 PMid:12666059 DOI: https://doi.org/10.1016/S0272-6386(03)00020-9

Fouad M, Ismail MI, Gaballah A, Reyad E, ELdeeb S. Prevalence of obesity and risk of chronic kidney disease among young adults in Egypt. Indian J Nephrol. 2016;26(6):413-8. https://doi.org/10.4103/0971-4065.172597 PMid:27942172 DOI: https://doi.org/10.4103/0971-4065.172597

Basdevant A, Cassuto D, Gibault T, Raison J, Guy-Grand B. Microalbuminuria and body fat distribution in obese subjects. Int J Obes Relat Metab Disord. 1994;18(12):806-11. PMid:7894519